Loading…
Synthesis, biological evaluation and structure–activity correlation study of a series of imidazol-based compounds as Candida albicans inhibitors
A new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives was synthesized. The antifungal activity was evaluated in vitro against different fungal species. The biological results show that the most active compounds possess an antifungal activity comparable or higher than Fluconazole against C...
Saved in:
Published in: | European journal of medicinal chemistry 2014-08, Vol.83, p.665-673 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c362t-128b4d1ec18d7c5215153cb7601292b635f0155ffe83c40a359f70d302668d1c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c362t-128b4d1ec18d7c5215153cb7601292b635f0155ffe83c40a359f70d302668d1c3 |
container_end_page | 673 |
container_issue | |
container_start_page | 665 |
container_title | European journal of medicinal chemistry |
container_volume | 83 |
creator | Moraca, Francesca De Vita, Daniela Pandolfi, Fabiana Di Santo, Roberto Costi, Roberta Cirilli, Roberto D’Auria, Felicia Diodata Panella, Simona Palamara, Anna Teresa Simonetti, Giovanna Botta, Maurizio Scipione, Luigi |
description | A new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives was synthesized. The antifungal activity was evaluated in vitro against different fungal species. The biological results show that the most active compounds possess an antifungal activity comparable or higher than Fluconazole against Candida albicans, non-albicans Candida species, Cryptococcus neoformans and dermathophytes. Because of their racemic nature, the most active compounds 5f and 6c were tested as pure enantiomers. For 6c the (R)-enantiomer resulted more active than the (S)-one, otherwise for 5f the (S)-enantiomer resulted the most active. To rationalize the experimental data, a ligand-based computational study was carried out; the results of the modelling study show that (S)-5f and (R)-6c perfectly align to the ligand-based model, showing the same relative configuration. Preliminary studies on the human lung adenocarcinoma epithelial cells (A549) have shown that 6c, 5e and 5f possess a low cytotoxicity.
[Display omitted]
•New 2-(1H-imidazol-1-yl)-1-phenylethanols were synthesized and evaluated as antifungal.•The most active compounds possess an antifungal activity comparable or higher than Fluconazole.•The most active compounds were synthesized and tested as pure enantiomers.•A ligand-based computational study was carried out to rationalize the experimental data.•Active compounds possess a low cytotoxicity on the human lung adenocarcinoma epithelial cells (A549). |
doi_str_mv | 10.1016/j.ejmech.2014.07.001 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1549178794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523414006072</els_id><sourcerecordid>1549178794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-128b4d1ec18d7c5215153cb7601292b635f0155ffe83c40a359f70d302668d1c3</originalsourceid><addsrcrecordid>eNp9kcGO1DAMhiMEYmcX3gChHDnQ4iRN27kgoREsSCtxAM5RmrhMRm0zxOlIw4lngDfkSeioC0dOtuTv9y_7Z-yZgFKAqF8dSjyM6PalBFGV0JQA4gHbiKZuCyV19ZBtQEpVaKmqK3ZNdAAAXQM8ZldSg4Ctajbs56fzlPdIgV7yLsQhfg3ODhxPdphtDnHidvKccppdnhP-_vHLuhxOIZ-5iynhsEKUZ3_mseeWE6aAdOnDGLz9Hoeis4R-4cdjnCdP3BLfLWuXKbdDtxhOxMO0D13IMdET9qi3A-HT-3rDvrx7-3n3vrj7ePth9-aucKqWuRCy7Sov0InWN05LoYVWrmtqEHIru1rpHoTWfY-tchVYpbd9A16BrOvWC6du2It17zHFbzNSNmMgh8NgJ4wzGaGrrWjaZlstaLWiLkWihL05pjDadDYCzCUNczBrGuaShoHGLGkssuf3DnM3ov8n-vv-BXi9ArjceQqYDLmAk0MfErpsfAz_d_gDOqagqQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1549178794</pqid></control><display><type>article</type><title>Synthesis, biological evaluation and structure–activity correlation study of a series of imidazol-based compounds as Candida albicans inhibitors</title><source>Elsevier</source><creator>Moraca, Francesca ; De Vita, Daniela ; Pandolfi, Fabiana ; Di Santo, Roberto ; Costi, Roberta ; Cirilli, Roberto ; D’Auria, Felicia Diodata ; Panella, Simona ; Palamara, Anna Teresa ; Simonetti, Giovanna ; Botta, Maurizio ; Scipione, Luigi</creator><creatorcontrib>Moraca, Francesca ; De Vita, Daniela ; Pandolfi, Fabiana ; Di Santo, Roberto ; Costi, Roberta ; Cirilli, Roberto ; D’Auria, Felicia Diodata ; Panella, Simona ; Palamara, Anna Teresa ; Simonetti, Giovanna ; Botta, Maurizio ; Scipione, Luigi</creatorcontrib><description>A new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives was synthesized. The antifungal activity was evaluated in vitro against different fungal species. The biological results show that the most active compounds possess an antifungal activity comparable or higher than Fluconazole against Candida albicans, non-albicans Candida species, Cryptococcus neoformans and dermathophytes. Because of their racemic nature, the most active compounds 5f and 6c were tested as pure enantiomers. For 6c the (R)-enantiomer resulted more active than the (S)-one, otherwise for 5f the (S)-enantiomer resulted the most active. To rationalize the experimental data, a ligand-based computational study was carried out; the results of the modelling study show that (S)-5f and (R)-6c perfectly align to the ligand-based model, showing the same relative configuration. Preliminary studies on the human lung adenocarcinoma epithelial cells (A549) have shown that 6c, 5e and 5f possess a low cytotoxicity.
[Display omitted]
•New 2-(1H-imidazol-1-yl)-1-phenylethanols were synthesized and evaluated as antifungal.•The most active compounds possess an antifungal activity comparable or higher than Fluconazole.•The most active compounds were synthesized and tested as pure enantiomers.•A ligand-based computational study was carried out to rationalize the experimental data.•Active compounds possess a low cytotoxicity on the human lung adenocarcinoma epithelial cells (A549).</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2014.07.001</identifier><identifier>PMID: 25010937</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Antifungal ; Antifungal Agents - chemical synthesis ; Antifungal Agents - chemistry ; Antifungal Agents - pharmacology ; Antifungal Agents - toxicity ; Azole derivatives ; Candida albicans - drug effects ; Candida albicans - enzymology ; Cell Line ; Chemistry Techniques, Synthetic ; Enantioselective synthesis ; Humans ; Imidazoles - chemical synthesis ; Imidazoles - chemistry ; Imidazoles - pharmacology ; Imidazoles - toxicity ; Ligand-based drug design ; Models, Molecular ; Protein Conformation ; Sterol 14-Demethylase - chemistry ; Sterol 14-Demethylase - metabolism ; Structure-Activity Relationship</subject><ispartof>European journal of medicinal chemistry, 2014-08, Vol.83, p.665-673</ispartof><rights>2014 Elsevier Masson SAS</rights><rights>Copyright © 2014 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-128b4d1ec18d7c5215153cb7601292b635f0155ffe83c40a359f70d302668d1c3</citedby><cites>FETCH-LOGICAL-c362t-128b4d1ec18d7c5215153cb7601292b635f0155ffe83c40a359f70d302668d1c3</cites><orcidid>0000-0003-4321-4626</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25010937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moraca, Francesca</creatorcontrib><creatorcontrib>De Vita, Daniela</creatorcontrib><creatorcontrib>Pandolfi, Fabiana</creatorcontrib><creatorcontrib>Di Santo, Roberto</creatorcontrib><creatorcontrib>Costi, Roberta</creatorcontrib><creatorcontrib>Cirilli, Roberto</creatorcontrib><creatorcontrib>D’Auria, Felicia Diodata</creatorcontrib><creatorcontrib>Panella, Simona</creatorcontrib><creatorcontrib>Palamara, Anna Teresa</creatorcontrib><creatorcontrib>Simonetti, Giovanna</creatorcontrib><creatorcontrib>Botta, Maurizio</creatorcontrib><creatorcontrib>Scipione, Luigi</creatorcontrib><title>Synthesis, biological evaluation and structure–activity correlation study of a series of imidazol-based compounds as Candida albicans inhibitors</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>A new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives was synthesized. The antifungal activity was evaluated in vitro against different fungal species. The biological results show that the most active compounds possess an antifungal activity comparable or higher than Fluconazole against Candida albicans, non-albicans Candida species, Cryptococcus neoformans and dermathophytes. Because of their racemic nature, the most active compounds 5f and 6c were tested as pure enantiomers. For 6c the (R)-enantiomer resulted more active than the (S)-one, otherwise for 5f the (S)-enantiomer resulted the most active. To rationalize the experimental data, a ligand-based computational study was carried out; the results of the modelling study show that (S)-5f and (R)-6c perfectly align to the ligand-based model, showing the same relative configuration. Preliminary studies on the human lung adenocarcinoma epithelial cells (A549) have shown that 6c, 5e and 5f possess a low cytotoxicity.
[Display omitted]
•New 2-(1H-imidazol-1-yl)-1-phenylethanols were synthesized and evaluated as antifungal.•The most active compounds possess an antifungal activity comparable or higher than Fluconazole.•The most active compounds were synthesized and tested as pure enantiomers.•A ligand-based computational study was carried out to rationalize the experimental data.•Active compounds possess a low cytotoxicity on the human lung adenocarcinoma epithelial cells (A549).</description><subject>Antifungal</subject><subject>Antifungal Agents - chemical synthesis</subject><subject>Antifungal Agents - chemistry</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antifungal Agents - toxicity</subject><subject>Azole derivatives</subject><subject>Candida albicans - drug effects</subject><subject>Candida albicans - enzymology</subject><subject>Cell Line</subject><subject>Chemistry Techniques, Synthetic</subject><subject>Enantioselective synthesis</subject><subject>Humans</subject><subject>Imidazoles - chemical synthesis</subject><subject>Imidazoles - chemistry</subject><subject>Imidazoles - pharmacology</subject><subject>Imidazoles - toxicity</subject><subject>Ligand-based drug design</subject><subject>Models, Molecular</subject><subject>Protein Conformation</subject><subject>Sterol 14-Demethylase - chemistry</subject><subject>Sterol 14-Demethylase - metabolism</subject><subject>Structure-Activity Relationship</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kcGO1DAMhiMEYmcX3gChHDnQ4iRN27kgoREsSCtxAM5RmrhMRm0zxOlIw4lngDfkSeioC0dOtuTv9y_7Z-yZgFKAqF8dSjyM6PalBFGV0JQA4gHbiKZuCyV19ZBtQEpVaKmqK3ZNdAAAXQM8ZldSg4Ctajbs56fzlPdIgV7yLsQhfg3ODhxPdphtDnHidvKccppdnhP-_vHLuhxOIZ-5iynhsEKUZ3_mseeWE6aAdOnDGLz9Hoeis4R-4cdjnCdP3BLfLWuXKbdDtxhOxMO0D13IMdET9qi3A-HT-3rDvrx7-3n3vrj7ePth9-aucKqWuRCy7Sov0InWN05LoYVWrmtqEHIru1rpHoTWfY-tchVYpbd9A16BrOvWC6du2It17zHFbzNSNmMgh8NgJ4wzGaGrrWjaZlstaLWiLkWihL05pjDadDYCzCUNczBrGuaShoHGLGkssuf3DnM3ov8n-vv-BXi9ArjceQqYDLmAk0MfErpsfAz_d_gDOqagqQ</recordid><startdate>20140818</startdate><enddate>20140818</enddate><creator>Moraca, Francesca</creator><creator>De Vita, Daniela</creator><creator>Pandolfi, Fabiana</creator><creator>Di Santo, Roberto</creator><creator>Costi, Roberta</creator><creator>Cirilli, Roberto</creator><creator>D’Auria, Felicia Diodata</creator><creator>Panella, Simona</creator><creator>Palamara, Anna Teresa</creator><creator>Simonetti, Giovanna</creator><creator>Botta, Maurizio</creator><creator>Scipione, Luigi</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4321-4626</orcidid></search><sort><creationdate>20140818</creationdate><title>Synthesis, biological evaluation and structure–activity correlation study of a series of imidazol-based compounds as Candida albicans inhibitors</title><author>Moraca, Francesca ; De Vita, Daniela ; Pandolfi, Fabiana ; Di Santo, Roberto ; Costi, Roberta ; Cirilli, Roberto ; D’Auria, Felicia Diodata ; Panella, Simona ; Palamara, Anna Teresa ; Simonetti, Giovanna ; Botta, Maurizio ; Scipione, Luigi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-128b4d1ec18d7c5215153cb7601292b635f0155ffe83c40a359f70d302668d1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Antifungal</topic><topic>Antifungal Agents - chemical synthesis</topic><topic>Antifungal Agents - chemistry</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antifungal Agents - toxicity</topic><topic>Azole derivatives</topic><topic>Candida albicans - drug effects</topic><topic>Candida albicans - enzymology</topic><topic>Cell Line</topic><topic>Chemistry Techniques, Synthetic</topic><topic>Enantioselective synthesis</topic><topic>Humans</topic><topic>Imidazoles - chemical synthesis</topic><topic>Imidazoles - chemistry</topic><topic>Imidazoles - pharmacology</topic><topic>Imidazoles - toxicity</topic><topic>Ligand-based drug design</topic><topic>Models, Molecular</topic><topic>Protein Conformation</topic><topic>Sterol 14-Demethylase - chemistry</topic><topic>Sterol 14-Demethylase - metabolism</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moraca, Francesca</creatorcontrib><creatorcontrib>De Vita, Daniela</creatorcontrib><creatorcontrib>Pandolfi, Fabiana</creatorcontrib><creatorcontrib>Di Santo, Roberto</creatorcontrib><creatorcontrib>Costi, Roberta</creatorcontrib><creatorcontrib>Cirilli, Roberto</creatorcontrib><creatorcontrib>D’Auria, Felicia Diodata</creatorcontrib><creatorcontrib>Panella, Simona</creatorcontrib><creatorcontrib>Palamara, Anna Teresa</creatorcontrib><creatorcontrib>Simonetti, Giovanna</creatorcontrib><creatorcontrib>Botta, Maurizio</creatorcontrib><creatorcontrib>Scipione, Luigi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moraca, Francesca</au><au>De Vita, Daniela</au><au>Pandolfi, Fabiana</au><au>Di Santo, Roberto</au><au>Costi, Roberta</au><au>Cirilli, Roberto</au><au>D’Auria, Felicia Diodata</au><au>Panella, Simona</au><au>Palamara, Anna Teresa</au><au>Simonetti, Giovanna</au><au>Botta, Maurizio</au><au>Scipione, Luigi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis, biological evaluation and structure–activity correlation study of a series of imidazol-based compounds as Candida albicans inhibitors</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2014-08-18</date><risdate>2014</risdate><volume>83</volume><spage>665</spage><epage>673</epage><pages>665-673</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><abstract>A new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives was synthesized. The antifungal activity was evaluated in vitro against different fungal species. The biological results show that the most active compounds possess an antifungal activity comparable or higher than Fluconazole against Candida albicans, non-albicans Candida species, Cryptococcus neoformans and dermathophytes. Because of their racemic nature, the most active compounds 5f and 6c were tested as pure enantiomers. For 6c the (R)-enantiomer resulted more active than the (S)-one, otherwise for 5f the (S)-enantiomer resulted the most active. To rationalize the experimental data, a ligand-based computational study was carried out; the results of the modelling study show that (S)-5f and (R)-6c perfectly align to the ligand-based model, showing the same relative configuration. Preliminary studies on the human lung adenocarcinoma epithelial cells (A549) have shown that 6c, 5e and 5f possess a low cytotoxicity.
[Display omitted]
•New 2-(1H-imidazol-1-yl)-1-phenylethanols were synthesized and evaluated as antifungal.•The most active compounds possess an antifungal activity comparable or higher than Fluconazole.•The most active compounds were synthesized and tested as pure enantiomers.•A ligand-based computational study was carried out to rationalize the experimental data.•Active compounds possess a low cytotoxicity on the human lung adenocarcinoma epithelial cells (A549).</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>25010937</pmid><doi>10.1016/j.ejmech.2014.07.001</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-4321-4626</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0223-5234 |
ispartof | European journal of medicinal chemistry, 2014-08, Vol.83, p.665-673 |
issn | 0223-5234 1768-3254 |
language | eng |
recordid | cdi_proquest_miscellaneous_1549178794 |
source | Elsevier |
subjects | Antifungal Antifungal Agents - chemical synthesis Antifungal Agents - chemistry Antifungal Agents - pharmacology Antifungal Agents - toxicity Azole derivatives Candida albicans - drug effects Candida albicans - enzymology Cell Line Chemistry Techniques, Synthetic Enantioselective synthesis Humans Imidazoles - chemical synthesis Imidazoles - chemistry Imidazoles - pharmacology Imidazoles - toxicity Ligand-based drug design Models, Molecular Protein Conformation Sterol 14-Demethylase - chemistry Sterol 14-Demethylase - metabolism Structure-Activity Relationship |
title | Synthesis, biological evaluation and structure–activity correlation study of a series of imidazol-based compounds as Candida albicans inhibitors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A25%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis,%20biological%20evaluation%20and%20structure%E2%80%93activity%20correlation%20study%20of%20a%20series%20of%20imidazol-based%20compounds%20as%20Candida%20albicans%20inhibitors&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Moraca,%20Francesca&rft.date=2014-08-18&rft.volume=83&rft.spage=665&rft.epage=673&rft.pages=665-673&rft.issn=0223-5234&rft.eissn=1768-3254&rft_id=info:doi/10.1016/j.ejmech.2014.07.001&rft_dat=%3Cproquest_cross%3E1549178794%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-128b4d1ec18d7c5215153cb7601292b635f0155ffe83c40a359f70d302668d1c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1549178794&rft_id=info:pmid/25010937&rfr_iscdi=true |